Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Exosomes can improve skin health and offer new treatments for skin repair and rejuvenation.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Ultrasound shows 80% of Hidradenitis Suppurativa patients have abnormal hair tracts that may worsen the condition.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Newly found stem cells in horse hooves show promise for treating a hoof disease called laminitis.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

The document recommends a team-based approach and personalized care for managing diabetes in teenagers.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

Norwegian puffin dogs have a unique type of hair loss that often doesn't get better on its own and responds well to ciclosporin treatment.